A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study [featured_image] Download Version Download 3 File Size 1.09 MB File Count 1 Create Date October 9, 2020 Last Updated October 20, 2020 A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study